What actions did the drugs regulator recommend to the states after WHO alerts
Understand the measures suggested by the drugs regulator to combat the sale of falsified versions of certain drugs.
After WHO alerts about the sale of falsified versions of certain drugs, the drugs regulator recommended the following measures to the states:
- Strengthening regulatory systems: States were advised to improve their monitoring and surveillance systems to effectively identify and track falsified drugs in the market.
- Enhancing collaboration and information sharing: The drugs regulator emphasized the importance of regular communication and data sharing among state regulatory authorities, healthcare professionals, and other stakeholders to detect and prevent the sale of counterfeit drugs.
- Increasing awareness: It was suggested that states should conduct public awareness campaigns to educate the general population about the risks associated with falsified drugs and how to identify them.
- Strengthening supply chain management: The drugs regulator recommended implementing robust supply chain management practices to ensure the integrity of drug distribution, including stringent quality checks and inspections.
- Strict legal action: States were urged to take stringent legal measures against individuals or organizations involved in the manufacturing, distribution, and sale of falsified drugs, including imposing heavy fines and penalties.
Answered
a year ago